Tandem Diabetes Care (TNDM) Other Working Capital Changes (2013 - 2026)

Tandem Diabetes Care has reported Other Working Capital Changes for 14 years, with the latest figure at $7.9 million in Q1 2026.

• For the quarter ending Q1 2026, Other Working Capital Changes rose 594.49% year-over-year to $7.9 million; the trailing twelve-month figure through Mar 2026 stood at $13.9 million (up 219.07% YoY), and the FY2025 full-year result was $4.4 million, down 21.6% from the prior year.
• Other Working Capital Changes for Q1 2026 stood at $7.9 million, up from -$7.8 million in the prior quarter.
• The five-year high for Other Working Capital Changes was $9.8 million in Q3 2025, with the low at -$7.8 million in Q4 2025.
• Historically, Other Working Capital Changes has averaged $2.0 million across 5 years, with a median of $1.1 million in 2022.
• Annual changes were most pronounced in 2023 — Other Working Capital Changes sank 673.71% — and 2024, when it soared 2445.41%.
• Tandem Diabetes Care's Other Working Capital Changes stood at $7.3 million in 2022, then advanced by 25.57% to $9.2 million in 2023, then tumbled by 114.51% to -$1.3 million in 2024, then tumbled by 483.42% to -$7.8 million in 2025, then surged by 201.48% to $7.9 million in 2026.
• The last three Other Working Capital Changes figures came in at $7.9 million (Q1 2026), -$7.8 million (Q4 2025), and $9.8 million (Q3 2025), per Business Quant data.